http://orcid.org/0000-0002-2973-1099
References
- Adolphe, A.B., et al., 1977. Preliminary pharmacokinetics of streptozotocin, an antineoplastic antibiotic. Journal of Clinical Pharmacology, 17 (7), 379–388.
- Blasiak, J., et al., 2004. DNA damage and repair in type 2 diabetes mellitus. Mutation Research, 554 (1–2), 297–304.
- Brownlee, M., 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414 (6865), 813–820.
- Damasceno, D.C., et al., 2002. Radicais livres, estresse oxidativo e diabete. Diabetes Clínica, 5, 355–361.
- Eleazu, C.O., et al., 2013. Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. Journal of Diabetes and Metabolic Disorders, 12 (1), 60.
- Giacco, F. and Brownlee, M., 2010. Oxidative stress and diabetic complications. Circulation Research, 107 (9), 1058–1070.
- Gorovits, N. and Charron, M.J., 2003. Mini-series: modern metabolic concepts. What we know about facilitative glucose transporters-lessons from cultured cells, animal models, and human studies. Biochemistry and Molecular Biology Education, 31 (3), 163–172.
- Junod, A., et al., 1969. Diabetogenic action of streptozotocin: relationship of dose of metabolic response. Journal of Clinical Investigation, 48 (11), 2129–2139.
- Karunanayake, E.H., Hearse, D.J., and Mellows, G., 1974. The synthesis of [14C] streptozotocin and its distribution and excretion in the rat. The Biochemical Journal, 142 (3), 673–683.
- Kaur, G., et al., 2016. Garlic and resveratrol attenuate diabetic complications, loss of β-cells, pancreatic and hepatic oxidative stress in streptozotocin-induced diabetic rats. Frontiers in Pharmacology, 7, 360.
- LeDoux, S.P., et al., 1986. Mechanisms of nitrosourea-induced beta-cell damage. Alterations in DNA. Diabetes, 35 (8), 866–872.
- Lenzen, S., 2008. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia, 51 (2), 216–226.
- Lima, P.H., et al., 2012. Genotoxicity evaluation in severe or mild diabetic pregnancy in laboratory animals. Experimental and Clinical Endocrinology & Diabetes, 120 (5), 303–307.
- Macintyre, A.N., et al., 2014. The glucose transporte-r GLUT-1 is selectively essential for cd4 T-cell activation and effector function. Cell Metabolism, 20 (1), 61–72.
- MacIver, N.J., et al., 2008. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. Journal of Leukocyte Biology, 84 (4), 949–957.
- McGowan, J.E., et al., 2006. Increased mitochondrial reactive oxygen species production in newborn brain during hypoglycemia. Neuroscience Letters, 399 (1–2), 111–114.,
- Nahdi, A.M.T.A., John, A., and Raza, H., 2017. Elucidation of molecular mechanisms of streptozotocin-induced oxidative stress, apoptosis, and mitochondrial dysfunction in rin-5f pancreatic β-cells. Oxidative Medicine and Cellular Longevity, 70, 42–72.
- Naziroğlu, M. and Butterworth, P.J., 2005. Protective effects of moderate exercise with dietary vitamin C and E on blood antioxidative defense mechanism in rats with streptozotocin-induced diabetes. Canadian Journal of Applied Physiology, 30 (2), 172–185.
- Petzold, G.L. and Swenberg, J.A., 1978. Detection of DNA damage induced in vivo following exposure of rats to carcinogens. Cancer Research, 38 (6), 1589–1594.
- Rahimi, R., et al., 2005. A review on the role of antioxidants in the management of diabetes and its complications. Biomedicine & Pharmacotherapy, 59 (7), 365–373.
- Singh, P., Jain, A., and Kaur, G., 2004. Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage. Molecular and Cellular Biochemistry, 260 (1–2), 153–159.
- Vikram, A., et al., 2007. Evaluation of streptozotocin genotoxicity in rats from different ages using the micronucleus assay. Regulatory Toxicology and Pharmacology, 49 (3), 238–244.
- Wu, J., and Yan, L.J., 2015. Streptozotocin-induced a type I diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity. Journal of Diabetes Metabolism Syndrome and Obesitity: Targets and Therapy, 8, 181–188.
- Xu, G.W., et al., 2004. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients. Journal of Pharmaceutical and Biomedical Analysis, 36 (1), 101–104.
- Yamamoto, H., Uchigata, Y., and Okamoto, H., 1981. Streptozotocin and alloxan induced DNA strand breaks and poly(ADP-ribose)synthetase in pancreatic islets. Nature, 294 (5838), 284–286.